Nevro Medical (NVRO): Enterprise Value to EBITDA Ratio
Nevro Corp. (NVRO) operates in the non-cyclical neurostimulation segment, where demand for procedures remains stable regardless of market fluctuations. This chart illustrates the current share value with an EV/EBITDA ratio of . The company relies on its exclusive HF10 technology, which provides significant pricing power. However, expansion is limited by US market saturation and a potential decline in profitability due to the costs of launching new products.
Comprehensive metric breakdowns and analytics for nevro.com (NVRO)
- stock price and consensus target price:
- stock exchange capitalization data:
- business book valuation details:
- debt obligations and liquidity statistics:
- financial results and valuation multiples details:
NVRO - Net Financial Result|Projected Future Earnings Nevro Corp.|NVRO - Price to Earnings Ratio|Forward P/E Multiple Nevro Corp.|NVRO - PEG Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Nevro Medical|NVRO - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Nevro|NVRO - Earnings per share for the trailing year|Quarterly EPS earnings growth nevro.com|NVRO - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Nevro Corp.
Analysis of all company metrics:Nevro Corporation NVRO
The EV/EBITDA multiple compares the total value of a company's assets and debt with its operating profit before interest, taxes, depreciation, and amortization. By analyzing the EV/EBITDA dynamics of a capital-intensive company, an investor determines the degree of business overvaluation and identifies points of fundamental price reversal. For Nevro Corp. (NVRO), this indicator remains stable due to steady demand for spinal cord stimulation systems and the low sensitivity of the medical sector to economic cycles.
Competitor analysis
Dexcom Corp - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Penumbra Medical PEN|NOVT: Enterprise Value to EBITDA Ratio|haemonetics.com - Enterprise Value to Operating Income Before Depreciation Ratio|INSP: EV/EBITDA Multiple|PRCT - Total Company Value to Operating Income Before Depreciation Ratio|CNMD (CONMED Corp.) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Pulse Medical (PLSE)|Enterprise Value to EBITDA Ratio INMD (InMode Ltd.)|PMI (picardmedical.com) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Surmodics SRDX|SENS - Enterprise Value to EBITDA Ratio|NeuroPace Corp - EV/EBITDA Multiple|Company Value to EBITDA Tactile Systems Technology|SNWV: EV/EBITDA Multiple|Enterprise Value to Operating Income Before Depreciation OM|ELMD (SmartVest) - EV/EBITDA Multiple|LENSAR Inc. (LNSR) - Total Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple RCEL|Enterprise Value to EBITDA Ratio profoundmedical.com PROF|EV/EBITDA Multiple BDMD (Baird Medical)|EV/EBITDA Multiple EDAP TMS SA EDAP|APYX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ICCM: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|LUNG (pulmonx.com) - Enterprise Value to EBITDA Ratio|TELA Bio - Business Value to Operating Income Before Depreciation|CTSO (CytoSorbents Corp) - EV/EBITDA Multiple|Company Value to EBITDA sensushealthcare.com SRTS|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Zynex (ZYXI)|electrocore.com (ECOR) - Enterprise Value to EBITDA Multiple|Vicarious Surgical - Enterprise Value to EBITDA Ratio|EV/EBITDA Multiple Inspira Technologies Oxy B.H.N. Ltd. IINN|SeaStar Medical Holding - EV/EBITDA Multiple|Total Company Value to Operating Income Before Depreciation Ratio IRIDEX Corporation IRIX|ibs.inc (INBS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio XAIR (Beyond Air)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Profusa, Inc.|Enterprise Value to EBITDA Ratio STRATA Skin (SSKN)|EV/EBITDA Multiple GCTK|NAOV - Company Value to EBITDA|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Venus Concept VERO|NUWE: Enterprise Value to Operating Income Before Depreciation|AEMD: Enterprise Value to EBITDA Ratio|Asensus Surgical, Inc. - Enterprise Value to Operating Income Before Depreciation Ratio|Avinger, Inc. (AVGR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation BSGM|CUTR (Cutera) - EV/EBITDA Multiple|Company Value to EBITDA Know Labs Inc KNW|Enterprise Value to EBITDA Ratio NARI (Inari)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization RSLS (reshapelifesciences.com)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Silk Road Medical, Inc SILK
